Henan Chuangxin Biological Technology Co., Ltd
Adults with type 2 diabetes and obesity lose less weight on EVERY GLP-1 drug compared to those without diabetes, consistently ~5% less
doi:10.1007/s00508-020-01662-5 Yoon SJ, Choi SR, Kim DM, et al
Nevertheless, enhanced abundance of DPP4 within adipose tissue of obese subjects may be involved in adipose tissue remodeling and substantially augments the lipolytic activity of enlarged adipocytes ( Moreover, dendritic cells and macrophages resident in visceral adipose depots exhibit an increased DPP4 expression in response to inflammation or in the obese state ( Adipose Tissue as Relevant Source of Circulating DPP4 Serum levels of sDPP4 are altered in many pathophysiologic conditions, including different types of cancer, allergic asthma, or hepatitis C ( Endocrine Effects of Soluble DPP4 Although there is clear evidence that increased circulating levels of sDPP4 are associated with hallmarks of obesity and type diabetes, such as whole-body IR, elevated BMI, and adipocyte hypertrophy, there are only few studies investigating the endocrine effects of sDPP4
They can effectively activate GPER without affecting other estrogen receptors (including ER and ER) [250]
.png)
